Bio-Rad's Q3 Revenues Increase 2 Percent amid 'Weak' Markets | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Bio-Rad Laboratories reported after the close of the market Tuesday a 2 percent increase in its third-quarter revenues year over year, falling short of analysts' consensus estimate.

The Hercules, Calif.-based life sciences and diagnostics products firm brought in total revenues of $471.5 million for the three months ended Sept. 30, compared to revenues of $461.1 million for the third quarter of 2009. Analysts had expected revenues of $476.7 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: carbapenem resistance in Enterobacteriaceae, selection against educational attainment-linked variants, and more.

Technology Review points out that a new US presidential science advisor hasn't been selected.

Researchers find that blood tests might be able to help determine severity of a concussion, Wired reports.

President-elect Donald Trump considers other candidates for director of the National Institutes of Health, Nature News reports.